Dr. John-Ioannis Grigoriadis

Scientific Director of Birgeneau Pharmaceuticals Ltd, GREECE

Biogenea Pharmaceuticals Ltd


Grigoriadis Ioannis completed his Pharmacist D at the age of 24 years from the Aristotle University of Thessaloniki. He is the scientific director of Biogenea Pharmaceuticals Ltd, a premier biotechnology personalized cancer vaccination service organization. He has published more than 20 papers in reputed journals and has been serving as an editorial board member of reputeon the collection, processing, cryopreservation, and cGMP (according to Good Manufacturing Practice) production -for solely autologous use – of cellular therapeutical solutions from blood (bone marrow, peripheral blood, cord blood) or blood compounds for human use -on stem cell expansion technologies, which were created in the research laboratories of NASA (National Aeronautics and Space Administration) – on the cGMP production of advanced medicinal products (1394/2007/ΕC) for solely autologous use from the skin, dental pulp, cord tissue). (In preclinical-research phase: 2008-2009) – on certified genetic analyses in collaboration with International Referral Centers -on copyright protection according to the American and/or European Copyright Agency

Follow Us